The effects of B7-dependent costimulation on T cell division and survival in vivo and in vitro are dependent on antigen concentration

European Journal of Immunology

Volumn 33, Issue 8, 2003, Pages 2074-2082

  Lumsden, Joanne M ^a,b   Prasad, Simon J ^a   Peach, Robert J ^c   Ronchese, Franca ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BIOGEN   (United States)

Author keywords

Antigen presentation; Costimulation; Processing; T lymphocytes

Indexed keywords

B7 ANTIGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; HYBRID PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 2; LIGAND; T LYMPHOCYTE RECEPTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY; DNA SYNTHESIS; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; CYTOCHROME C GROUP; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; THYMIDINE;

EID: 0041474771     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323929     Document Type: Article

References (36)

1. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P., CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 1992. 356: 607-609.
2. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, P., Singh, C. and Tepper, M. A., Immunosuppression in vivo by a soluble form of the CTLA4 T cell activation molecule. Science 1992. 257: 792-795.
3. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992. 257: 789-792.
4. Turka, L. A., Linsley, P. S., Lin, H. et al., T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 1992. 89: 11102-11105.
5. Harris, N., Peach, R., Naemura, J., Linsley, P. S., Le Gros, G. and Ronchese, F., CD80 costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 1997. 185: 177-182.
6. Finck, B. K., Linsley, P. S. and Wofsy, D., Treatment of murine lupus with CTLA4Ig. Science 1994. 265: 1225-1227.
7. Griggs, N. D., Agersborg, S. S., Noelle, R. J., Ledbetter, J. A., Linsley, P. S. and Tung, K. S., The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 1996. 183: 801-810.
8. Perrin, P. J., Scott, D., Quigley, L., Albert, P. S., Feder, O., Gray, G. S., Abe, R., June, C. H. and Racke, M. K., Role of B7:CD28/CTLA4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 1995. 154: 1481-1490.
9. Borriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J. and Sharpe, A. H., B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997. 6: 303-313.
10. Chang, T. T., Jabs, C., Sobel, R., Kuchroo, V. K. and Sharpe, A. H., Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 1999. 190: 733-740.
11. Mark, D. A., Donovan, C. E., De Sanctis, G. T., He, H. Z., Cernadas, M., Kobzik, L., Perkins, D. L., Sharpe, A. and Finn, P. W., B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 2000. 22: 265-271.
12. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
13. Gett, A. V. and Hodgkin, P. D., A cellular calculus for signal integration by T cells. Nat. Immunol. 2000. 1: 239-244.
14. Lyons, A. B. and Parish, C. R., Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994. 171: 131-137.
15. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA4. J. Immunol. 1995. 155: 1032-1036.
16. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. and Loh, D. Y., Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 1995. 154: 5757-5768.
17. Noel, P. J., Boise, L. H., Green, J. M. and Thompson, C. B., CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 1996. 157: 636-642.
18. Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B. and Bluestone, J. A., CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 1996. 157: 3909-3917.
19. Iezzi, G., Karjalainen, K. and Lanzavecchia, A., The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998. 8: 89-95.
20. L. Immunity 1995. 3: 87-98.
21. Sepulveda, H., Cerwenka, A., Morgan, T. and Dutton, R. W., CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 1999. 163: 1133-1142.
22. Gudmundsdottir, H., Wells, A. D. and Turka, L. A., Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 1999. 162: 5212-5223.
23. Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B., Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989. 244: 339-343.
24. Chen, C. Y., Del Gatto-Konczalk, F., Wu, Z. and Karin, M., Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998. 280: 1945-1949.
25. Fraser, J. D., Irving, B. A., Crabtree, G. R. and Weiss, A., Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991. 251: 313-316.
26. + helper T cells. A model for the long-term survival of memory cells. J. Immunol. 1996. 156: 1764-1771.
27. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A. and Thompson, C. B., Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994. 1: 501-508.
28. Appleman, L. J., Berezovskaya, A., Grass, I. and Boussiotis, V. A., CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 2000. 164: 144-151.
29. Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S. and Rottapel, R., A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2001. 2: 325-332.
30. L restores cell survival, but not proliferation and effector differentiation, in CD28-deficient T lymphocytes. J. Exp. Med. 2000. 191: 2031-2037.
31. Wells, A. D., Walsh, M. C., Bluestone, J. A. and Turka, L. A., Signaling through CD28 and CTLA4 controls two distinct forms of T cell anergy. J. Clin. Invest. 2001. 108: 895-904.
32. Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B. and Abbas, A. K., Induction of peripheral T cell tolerance in vivo requires CTLA4 engagement. Immunity 1997. 6: 411-417.
33. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. and Sharpe, A. H., CTLA4 regulates induction of anergy in vivo. Immunity 2001. 14: 145-155.
34. Egen, J. G. and Allison, J. P., Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002. 16: 23-35.
35. + transgenic T cells in spontaneous inflammatory bowel disease in lymphopenic mice. J. Immunol. 1999. 162: 7208-7216.
36. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A., CTLA4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991. 174: 561-569.